drugset / Trial / NCT01711346
A Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells
RandomizedCrossoverSingle-blind
Summary
The objective of this study is to assess the post-infusion viability of S-303 Red Blood Cells (RBC) by measuring the 24 hour post-infusion recovery and lifespan of autologous RBCs prepared with the S-303 Treatment System for RBC after storage for 35 days in comparison to conventional untreated RBCs stored for 35 days.
Timeline
- Start
- 2012-10
- Primary completion
- 2014-07
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Conventional, untreated Red Blood Cells (RBCs) | Unknown | — | Intravenous |
| Subject | S303 Red Blood Cells (RBCs) | Unknown | — | Intravenous |
Indications
No indication recorded.